Being overweight or obese may hide true nutritional status of patients with cancer
the ONA take:
Most cancer treatments—surgery, chemotherapy, radiation, or chemoradiation—can result in significant nutrition-related side effects; therefore, all patients should be screened for nutritional status, even obese patients. The nutritional status of overweight or obese patients may be deceiving.
Obesity increases the risk for cancer, and many patients are overweight or obese at diagnosis. But they appear to be well-nourished so they are not screened. Researchers at the chemotherapy department at Larissa General Clinic in Thessaly, Greece, conducted a study of 1,469 patients with advanced cancer; 594 of them were overweight or obese. Using nutritional screenings and questionnaires, the researchers determined if overweight or obese patients were well nourished, at risk, or malnourished.
The patients were asked about weight loss, mobility, psychological stress, medical history, eating habits, and their view of their own nutritional status. Study results indicated that 12% of the overweight and obese cancer patients were, in fact, malnourished and more than half were at risk for being malnourished.
Whether patients with cancer benefit from maintaining a heavy body weight or achieving some limited degree of weight loss is unclear.
However, these researchers and others stress that obesity or overweight status in a patient with a cancer diagnosis should not preclude nutritional screening, which is usually done by a nurse, because nutritional status can have a huge impact on quality of life, treatment response, and overall patient outcomes.
All patients should be screened for nutritional status, even obese patients.
Obese cancer patients also tend to survive longer than underweight patients and that may further discourage nutritional screening, they add.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|